Dose-Response Relationship: Potency and Efficacy
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
The Placebo Effect
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Sensitivity, Specificity, and Predicted Value
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 30, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Mirella Russo1,2,3, Tommaso Costa4, Dario Calisi1,2,3
1Department of Neuroscience, Imaging, and Clinical Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
No abstract available in PubMed .
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
10:33Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016